share_log

Insider Spends HK$478k Buying More Shares In EuroEyes International Eye Clinic

内部情報筋、徳視佳国際眼科クリニック株を購入しHK$478,000を費やす

Simply Wall St ·  02/02 17:06

Whilst it may not be a huge deal, we thought it was good to see that the EuroEyes International Eye Clinic Limited (HKG:1846) VP of Denmark & Executive Director, Jannik Jørgensen, recently bought HK$478k worth of stock, for HK$4.90 per share. However, it only increased their shares held by 1.6%, and it wasn't a huge purchase by absolute value, either.

EuroEyes International Eye Clinic Insider Transactions Over The Last Year

The Founder Jörn Jörgensen made the biggest insider purchase in the last 12 months. That single transaction was for HK$7.8m worth of shares at a price of HK$5.19 each. That means that even when the share price was higher than HK$4.95 (the recent price), an insider wanted to purchase shares. Their view may have changed since then, but at least it shows they felt optimistic at the time. To us, it's very important to consider the price insiders pay for shares. It is generally more encouraging if they paid above the current price, as it suggests they saw value, even at higher levels.

In the last twelve months insiders purchased 1.78m shares for HK$9.1m. On the other hand they divested 5.00k shares, for HK$29k. In total, EuroEyes International Eye Clinic insiders bought more than they sold over the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

insider-trading-volume
SEHK:1846 Insider Trading Volume February 2nd 2024

EuroEyes International Eye Clinic is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

Insider Ownership Of EuroEyes International Eye Clinic

Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. EuroEyes International Eye Clinic insiders own 58% of the company, currently worth about HK$949m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

What Might The Insider Transactions At EuroEyes International Eye Clinic Tell Us?

The recent insider purchases are heartening. And an analysis of the transactions over the last year also gives us confidence. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about EuroEyes International Eye Clinic. That's what I like to see! Of course, the future is what matters most. So if you are interested in EuroEyes International Eye Clinic, you should check out this free report on analyst forecasts for the company.

But note: EuroEyes International Eye Clinic may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする